Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Free CF Margin

-672.50%

Quarterly · Period ending:

LCTX logo

LCTX Free CF Margin

Latest reported-672.50%
LCTX Quarterly Free CF Margin (0.00% → -672.50%)
High-resolution chart · PNG

LCTX free cf margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Free CF Margin — Quarterly
Period endingFree CF Margin
-672.4977%
-471.4782%
-75.4994%
-98.5602%
-200.8318%
-331.7577%
-233.9958%
-156.0995%
-371.1648%
-403.1163%
-292.6245%
-415.4093%
-202.2946%
-479.0444%
-432.7415%
-192.3282%
-157.237%
417.3764%
-626.9792%
-223.2516%
-1,254.195%
-2,537.5427%
-3,412.6506%
-1,424.269%
-4,287.8788%
-3,033.7349%
-664.6635%
-3,461.7512%
-3,944.8%
-5,297.7654%
-3,992.9825%
-3,244.697%
-1,227.5578%
-3,022.9333%
-1,066.9596%
-1,757.4514%
-2,449.3438%
-2,190.7652%
-1,218.9974%
-2,407.9487%
-2,185.3755%
-2,587.5427%
-2,691.3514%
-1,557.381%
-2,170.7675%
-1,669.3705%
-2,047.7461%
-1,600.8944%
-2,346.5832%
-2,156.7637%
-708.3614%
-1,383.1158%
-1,469.3749%
-1,434.2942%
-1,001.9498%
-504.25%
-386.4536%
-923.1069%
-231.4574%
-335.7636%
-402.0421%
-473.5128%
-214.6996%
-247.836%
-270.5259%
-192.4496%
-116.3921%
-331.8817%
-216.7379%
-346.7812%
-480.2881%
-16.1806%
-183.4634%
-71.2927%
-100.1877%
-66.3967%
-166.0987%
-156.1824%
-40.5214%
-80.1156%
-62.6488%
-308.078%
156.8626%
-274.8403%
-177.8068%
-344.8742%
-103.1903%
-106.9855%
-198.1099%
-588.6366%
-183.8038%
483.4259%
-164.4655%
-580.5231%
-280.0197%
-541.5677%
-799.4787%
-1,162.3622%
-537.4338%
-3,037.6483%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.